Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11081594 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
Condition: - Postnasal Drainage
Intervention: Drug: Rabeprazole 20 mg twice a day for 90-day period treatment

Indicates status has not been verified in more than two years